Android app Apple app link

Shionogi awarded $375m from HHS for preventative Covid-19 injectable

By Yahoo! Finance   |   3 days ago
Shionogi awarded $375m from HHS for preventative Covid-19 injectable

Shionogi received $375m from HHS to develop a long-acting Covid-19 therapeutic, S-892216, funded through BARDA's Project NextGen. The drug uses protease inhibitor tech to prevent virus replication.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.